The Cardiac Arrhythmia Network of Canada (CANet) is accelerating their research with Heart-SIGN, a platform designed with IBM’s Watson Analytics and BigInsights on Cloud at its core.

Exciting innovation: @IBM & @CANet_nce help boost heart research with a new #analytics platform called, #HeartSIGN https://t.co/hgWZwOMQAF pic.twitter.com/9ZEnxGFF7q

— Michelle Zulauf (@ZulaufMichelle) October 21, 2016

As neuroscientists working on treatments for Parkinson’s Disease can attest, today’s healthcare researchers are inundated with massive amounts of big data. Heart-SIGN’s ability to synthesize CANet’s findings could reveal discoveries in the field that may have otherwise taken years.

Nathalie Le Prohon, Vice President at IBM Watson Health Life Sciences, says: “The ability for researchers and providers to utilize cognitive tools helps them to spend less time sifting through data and more time gaining insights and delivering transformation where we need it most.”

Excited to partner with @IBMCanada on #HeartSIGN. Helping researchers find answers faster. #arrhythmiaresearch… https://t.co/do3WxqpycU pic.twitter.com/59aPSr3tj7

— Nathalie Le Prohon (@NathLePro) October 21, 2016

Millions of Canadians experience some form of arrhythmia, or irregular heartbeats, a condition that can negatively impact productivity and overall quality of life. In some cases, arrhythmia can also lead to sudden cardiac death, resulting in the loss of 40,000 lives a year.